StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2022 - 08 - 12
1
2022 - 07 - 28
1
2022 - 07 - 18
1
2022 - 06 - 21
1
2021 - 10 - 06
2
2021 - 08 - 09
2
Sector
Health technology
8
N/a
3
Tags
Acer-001
10
Acer-801
7
Acquire
1
Acquisition
2
Alliances
1
Application
7
Approval
1
Biotech
1
Celiprolol
4
Ceo
1
Ces
2
China
1
Clinical-trials-phase-ii
3
Collaboration
4
Commercial
2
Commercialization
4
Conference
7
Designation
2
Disease
6
Drug
8
Earnings
3
Edsivo
2
Enroll
3
Europe
5
Events
2
Expected
2
Fda
12
Fda acceptance
2
Financial
5
Financial results
5
Genetown
11
Granted
2
Growth
2
License
2
Market
2
Meeting
2
Metabolic
4
N/a
46
Nasdaq
3
New drug
4
Patent
7
Pdufa
2
Pharmaceutical
5
Phase 3
2
Presentation
4
Rare
2
Research
3
Resubmission
2
Results
17
Review
2
Submission
4
Syndros
2
Therapeutics
54
Topline
3
Treatment
14
Trial
9
Update
9
Urea
12
Urine
4
Worldwide
2
Entities
Acer therapeutics inc.
8
Relief therapeutics holding sa
3
Symbols
ABBV
75
ABT
64
ALGS
17
ALNY
11
ALPMF
26
ALPMY
26
AMGN
54
ARDX
11
ARQT
11
ARVL
11
AZN
69
AZNCF
47
BAX
15
BDX
34
BHC
22
BIIB
28
BIO
12
BMY
63
BSX
13
CERT
11
CRL
13
DHR
14
ENDP
13
ENVB
12
EVOTF
20
FNCTF
27
GILD
25
GLAXF
76
GLPG
12
GSK
109
HOTH
12
IMAB
11
INBS
19
INCY
33
IONS
14
JAGX
33
JNJ
224
LEXX
11
LH
14
LLY
105
LTRN
33
MDT
24
MNKD
12
NNVC
21
NVO
18
NVS
115
NVSEF
85
PFE
54
PRGO
13
SNY
240
SNYNF
173
SRNE
11
STRO
12
TAK
29
TEVJF
44
TMO
48
TNXP
12
VTRS
15
WST
14
ZLAB
11
Exchanges
Nasdaq
8
Crawled Date
2022 - 08 - 12
1
2022 - 07 - 28
1
2022 - 07 - 18
1
2022 - 06 - 21
1
2021 - 10 - 06
2
2021 - 08 - 09
2
Crawled Time
07:00
1
13:00
3
13:20
1
14:00
1
15:20
1
16:00
1
Source
www.acertx.com
1
www.biospace.com
6
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Drug
symbols :
Acer
save search
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Published:
2022-08-12
(Crawled : 13:00)
- biospace.com/
RLFTF
|
$1.4
1.3K
|
n/a
|
3900.0%
|
O:
5.71%
H:
2.7%
C:
0.0%
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-39.19%
|
O:
1.36%
H:
4.0%
C:
-2.0%
acer-001
designation
drug
disease
urine
granted
therapeutics
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDsPrescription Drug User Fee Act (PDUFA) target action date set for January 15, 2023
Published:
2022-07-28
(Crawled : 15:20)
- biospace.com/
RLFTF
|
$1.4
1.3K
|
n/a
|
3821.57%
|
O:
3.08%
H:
0.0%
C:
-6.79%
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-37.06%
|
O:
0.7%
H:
4.86%
C:
-1.39%
acer-001
treatment
fda
drug
set
resubmission
therapeutics
review
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Published:
2022-07-18
(Crawled : 13:20)
- biospace.com/
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-41.33%
|
O:
4.3%
H:
1.87%
C:
0.0%
acer-001
treatment
drug
application
resubmission
therapeutics
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Published:
2022-06-21
(Crawled : 16:00)
- biospace.com/
RLFTF
|
$1.4
1.3K
|
n/a
|
4566.67%
|
O:
-21.33%
H:
27.12%
C:
14.41%
RLFTY
|
$1.4006
733.33%
100
|
n/a
|
-68.17%
|
O:
-15.91%
H:
8.65%
C:
8.65%
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-48.86%
|
O:
-10.23%
H:
0.0%
C:
0.0%
acer-001
fda
drug
application
therapeutics
review
update
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle DisordersFDA sets PDUFA target action date of June 5, 2022
Published:
2021-10-06
(Crawled : 14:00)
- biospace.com/
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-63.86%
|
O:
12.45%
H:
8.57%
C:
3.57%
urea
new drug
fda
fda acceptance
pdufa
drug
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders
Published:
2021-10-06
(Crawled : 13:00)
- acertx.com
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-63.86%
|
O:
12.45%
H:
8.57%
C:
3.57%
urea
new drug
fda
fda acceptance
drug
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
Published:
2021-08-09
(Crawled : 13:00)
- globenewswire.com
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-63.56%
|
O:
2.83%
H:
4.33%
C:
3.54%
urea
new drug
treatment
fda
drug
submission
RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
Published:
2021-08-09
(Crawled : 07:00)
- biospace.com/
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-63.56%
|
O:
2.83%
H:
4.33%
C:
3.54%
urea
new drug
treatment
fda
drug
submission
Gainers vs Losers
72%
28%
Top 10 Gainers
AGBA
|
$1.05
162.5%
100M
|
Finance
ISPC
|
$0.4621
116.95%
15M
|
Professional, Scientific, and T...
INVO
|
$1.515
99.34%
4.3M
|
Health Technology
BPTH
|
$5.62
73.46%
75M
|
Health Technology
TIRX
|
$0.8231
69.78%
54M
|
SINT
|
$0.0519
39.14%
350M
|
Health Technology
XPON
|
$2.63
36.27%
8.4M
|
VTNR
S
|
$1.26
28.68%
9.1M
|
Industrial Services
SWVL
|
$9.64
27.35%
200K
|
n/a
DFLI
A
|
$0.7726
25.52%
4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.